98%
921
2 minutes
20
: The methacholine bronchial provocation test (MBPT) is a diagnostic test frequently used to evaluate airway hyper-reactivity. MBPT is essential for diagnosing asthma; however, it can be time-consuming and resource-intensive. This study aimed to develop an artificial intelligence (AI) model to predict the MBPT results using forced expiratory volume in one second (FEV) and bronchodilator test measurements from spirometry. : a dataset of spirometry measurements, including Pre- and Post-bronchodilator FEV, was used to train and validate the model. : Among the evaluated models, the multilayer perceptron (MLP) achieved the highest area under the curve (AUC) of 0.701 (95% CI: 0.676-0.725), accuracy of 0.758, and an F1-score of 0.853. Logistic regression (LR) and a support vector machine (SVM) demonstrated comparable performance with AUC values of 0.688, while random forest (RF) and extreme gradient boost (XGBoost) achieved slightly lower AUC values of 0.669 and 0.672, respectively. Feature importance analysis of the MLP model identified key contributing features, including Pre-FEF (%), Pre-FVC (L), Post FEV/FVC, Change-FEV (L), and Change-FEF (%), providing insight into the interpretability and clinical applicability of the model. : These results highlight the potential of the model to utilize readily available spirometry data, particularly FEV and bronchodilator responses, to accurately predict MBPT results. Our findings suggest that AI-based prediction can improve asthma diagnostic workflows by minimizing the reliance on MBPT and enabling faster and more accessible assessments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11854253 | PMC |
http://dx.doi.org/10.3390/diagnostics15040449 | DOI Listing |
Eur Clin Respir J
August 2025
Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Unlabelled: Methacholine bronchial provocation (BMP) is a valuable tool in supporting the diagnosis of asthma, but the BMP must be validated regarding dosing, since the BMP basically is a dose response study. Historically, the dose delivered by a nebulizer has been calibrated gravimetrically, by weighing the nebulizer before and after dosing. However, this method is no longer recommended, since it has been recognized that a large fraction of the weight loss was due to evaporation.
View Article and Find Full Text PDFAllergy
August 2025
Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Background: The natural history of airway hyperresponsiveness (AHR) from childhood to adulthood and its association with asthma status are poorly understood. We aim to define the natural history of AHR in relation to asthma characteristics such as symptoms, atopy and lung function to improve our understanding of the changes in AHR with asthma pathophysiology during adolescence.
Methods: Methacholine bronchial challenge test (BCT) was undertaken in the Isle of Wight whole population birth cohort at 10 years (n = 783), 18 years (n = 585) and 26 years (n = 86).
Clin Chest Med
September 2025
Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan S7N 0W8, Canada.
This review article explores the methacholine challenge test (MCT), a bronchoprovocation technique used to assess airway hyperresponsiveness (AHR), a hallmark of asthma. The article begins by tracing the historical development of the MCT, including early studies that established its clinical relevance in diagnosing asthma. The physiological mechanisms underlying AHR are discussed, with emphasis on how these contribute to bronchoconstriction.
View Article and Find Full Text PDFLung
July 2025
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) - Université Laval, Pavillon A, Room 2089, 2725, Chemin Sainte-Foy, Québec, QC, G1V 4G5, Canada.
Introduction: A recent study on BALB/c and C57BL/6 mice demonstrated a clear lack of association between the in vivo response to nebulized methacholine and the degree of airway narrowing ex vivo in a model of asthma induced by a daily exposure to house dust mite over 10 consecutive days. This finding raises the question of which factors determine the methacholine response in vivo.
Methods: Herein, multiple linear regression analyses were used to determine which baseline physiological characteristics are associated with the methacholine response.
Pulm Med
July 2025
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Asthma diagnosis can be confirmed by observing significant bronchodilator response (BDR) through peak expiratory flow (PEF) at home or forced expiratory volume in 1 s (FEV) via spirometry in a clinical setting. We aimed to use the administration of salbutamol after a methacholine challenge test as a model of bronchodilation to study how accurately the change in PEF predicts improvement in lung function, as defined by an increase in FEV. We analyzed 869 adult patients who were administered salbutamol after a methacholine challenge.
View Article and Find Full Text PDF